HealthTree Logo HealthTree Foundation
Donate
HealthTree Logo
Donate
Personal Health Record
  • My Feed
  • Recently viewed

Learn

  • Topics
  • Events

Explore

  • Find treatments & trials
  • Participate in research
  • Find a coach
  • Find a specialist
  • Talk to a patient navigator
  • Get involved
  • For researchers
  • For healthcare providers
  • About us
  • Get involved
  • For researchers
  • For healthcare providers
  • About us

Create your Personal Health Record and unlock support built around you

Aligned with your diagnosis, treatment and where you are in your care. It lets HealthTree show you:

  • Treatments and trials you qualify for
  • Education for your stage of care
  • Financial support for your medications
  • Solutions to your side effects
Trial match for you
Matched on subtype and prior lines
Financial help
Support program for your current medication
Coach support
Coach suggestion with your same treatment path
Learn more about HealthTree
Trial match for you
Matched on subtype and prior lines
Financial help
Support program for your current medication
Coach support
Coach suggestion with your same treatment path
Video

BETA - What cardiotoxicities are associated with CAR-T treatment?

Posted by
HealthTree Logo HealthTree
• April 4, 2026

Description

Learn from cancer experts what cardiotoxicities are associated with CAR-T therapy for myeloma patients.

On this video

Healthtree contact Adam D. Cohen, MD

Adam D. Cohen, MD

Director, Myeloma Immunotherapy & Associate Professor of Medicine

Healthtree contact Christopher Ferreri, MD

Christopher Ferreri, MD

MD ANDERSON CANCER CENTER

Related Content

  • Event Navigating CAR-T Therapy: Understanding Side Effects and Staying Informed
  • Video CAR-T Side Effects: What Caregivers Should Watch For and When to Call
  • Video Delayed Neurotoxicity After BCMA CAR-T: Warning Signs for Caregivers
  • Video ICANS After CAR-T: Neurotoxicity Symptoms Caregivers Should Know
  • Video The CAR-T Revolution: Side Effects, Results & What's Next | Tara Gregory, MD
  • Video Beyond CRS & ICANS: Insights Into Delayed Neurotoxicity After BCMA CAR-T Therapy in Myeloma | #EHA26